Skip to main content
Premium Trial:

Request an Annual Quote

Canada s Structural Genomics Consortium Wins $95M Proteomics Grant

NEW YORK, April 3 - GlaxoSmithKline, the government of Ontario, and two regional research trusts have awarded Canada's Structural Genomics Consortium $95 million to perform proteomics studies into a number of diseases, the SGC said today.

 

The British pharma giant together with the government of Ontario Premier Ernie Eves, the Ontario Innovation Trust, and the Ontario Research and Development Challenge Fund have raised  the money to help the SGC investigate 350 human proteins links to certain cancers, neurological disorders, and infectious diseases.

 

The three-year project, which will be led by Canadian scientist Aled Edwards, involves scientists based at the University of Toronto and the University of Oxford, UK, the Wellcome Trust, Genome Canada, and Canadian Institutes of Health Research.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more